Shuang-zhe Lin
Xinhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
C/EBPβ-VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD.
Journal: JHEP reports : innovation in hepatology
Published: September 17, 2024
Transcriptomic Landscape Analysis Reveals a Persistent DNA Damage Response in Metabolic Dysfunction-associated Steatohepatitis Post-dietary Intervention.
Journal: Journal of clinical and translational hepatology
Published: March 23, 2024
Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study.
Journal: Health science reports
Published: October 12, 2023
Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis.
Journal: Molecular metabolism
Published: September 25, 2023
Prolyl endopeptidase remodels macrophage function as a novel transcriptional coregulator and inhibits fibrosis.
Journal: Experimental & molecular medicine
Published: November 17, 2022
Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease.
Journal: Journal of clinical and translational hepatology
Published: November 15, 2022
Peripheral immune cells in NAFLD patients: A spyhole to disease progression.
Journal: EBioMedicine
Published: October 26, 2021
Prolyl endopeptidase gene disruption attenuates high fat diet-induced nonalcoholic fatty liver disease in mice by improving hepatic steatosis and inflammation.
Journal: Annals of translational medicine
Published: April 21, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026